Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1360-1365

  Ngui, S L ^b   O'Connell, S ^b   Eglin, R P ^b   Heptonstall, J ^b   Teo, C G ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOTHER CHILD RELATION; NEWBORN; POLYMERASE CHAIN REACTION; POSTNATAL CARE; PRIORITY JOURNAL; TREATMENT FAILURE; UNITED KINGDOM; VACCINATION; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS GENE; VIRUS MUTANT;

EID: 0030782166     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514133     Document Type: Article

References (16)

1. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
2. Okamoto H, Yano K, Nozaki Y, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992;32:264-8.
3. 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992;184:1152-7.
4. Kathigesu VD, Allison LMC, Fortuin M, Mendy M, Whittle HC, Howard DR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994;75:443-8.
5. Hino K, Okuda M, Hashimoto O, et al. Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci 1995;3:566-70.
6. Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995;13:699-702.
7. Waters J, Kennedy M, Voet P, et al. Loss of the common a determinant of hepatitis B surface antigen by a vaccine induced escape mutant. J Clin Invest 1992;90:2543-7.
8. Hyams K. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20:992-1000.
9. Boom R, Sol CJA, Salimans MMM, et al. Rapid and simple method for purification of nucleic acids by using silica particles. J Clin Microbiol 1990;28:495-503.
10. Yusof HM, Flower AJE, Teo CG. Transmission of hepatitis B virus analysed by conformation-dependent polymorphisms of single-stranded viral DNA. J Infect Dis 1994;169:62-7.
11. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the Sgene. Intervirology 1995;38:24-33.
12. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.
13. Kohno H, Inoue T, Tsuda, Okamoto, Akahane Y. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996;77:1825-31.
14. Harrison TJ, Oon CJ, Zuckerman AJ. A novel antibody escape variant (ala 144) of hepatitis B virus in an identical twin before selection in the mother. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994:248-51.
15. Duarte EA, Novella IS, Weaver SC, et al. RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis 1994;3:201-14.
16. Surya IGP, Kishimoto S, Sudaryat S, et al. Prevention of mother-to-infant transmission of hepatitis B virus with use of a preS2-containing vaccine in Bali, Indonesia. Vaccine Res 1996;5:203-13.